Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

St. Judes-Stanford Comprehensive Support Initiative

NCT03154190 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03154190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
St. Judes-Stanford Comprehensive Support Initiative
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
August 8, 2017
Completion date
August 30, 2022
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, brain glioblastoma, estrogen receptor negative, extensive stage small cell lung carcinoma, head and neck carcinoma, her2/neu negative, hormone-resistant prostate cancer, limited stage small cell lung carcinoma, myelodysplastic syndrome, progesterone receptor negative, progressive disease, recurrent carcinoma, stage ii pancreatic cancer, stage ii rectal cancer, stage iia pancreatic cancer, stage iia rectal cancer, stage iib pancreatic cancer, stage iib rectal cancer, stage iic rectal cancer, stage iii colon cancer, stage iii esophageal cancer, stage iii gastric cancer, stage iii non-small cell lung cancer, stage iii ovarian cancer, stage iii pancreatic cancer, stage iii rectal cancer, stage iii skin melanoma, stage iiia colon cancer, stage iiia esophageal cancer, stage iiia gastric cancer, stage iiia non-small cell lung cancer, stage iiia ovarian cancer, stage iiia rectal cancer, stage iiia skin melanoma, stage iiib colon cancer, stage iiib esophageal cancer, stage iiib gastric cancer, stage iiib non-small cell lung cancer, stage iiib ovarian cancer, stage iiib rectal cancer, stage iiib skin melanoma, stage iiic colon cancer, stage iiic esophageal cancer, stage iiic gastric cancer, stage iiic ovarian cancer, stage iiic rectal cancer, stage iiic skin melanoma, stage iv bladder cancer, stage iv bone sarcoma, stage iv breast cancer, stage iv colon cancer, stage iv esophageal cancer, stage iv gastric cancer, stage iv non-small cell lung cancer, stage iv ovarian cancer, stage iv pancreatic cancer, stage iv rectal cancer, stage iv renal cell cancer, stage iv skin melanoma, stage iv soft tissue sarcoma, stage iva bone sarcoma, stage iva colon cancer, stage iva rectal cancer, stage ivb bone sarcoma, stage ivb colon cancer, stage ivb rectal cancer, triple-negative breast carcinoma